The present invention relates to a compound of Formula I, a pharmaceutical composition comprising the same and their use in the treatment or prevention of pathological conditions associated to depolarizing GABAergic transmission including, for example, Down syndrome and autism
| Patent title | Modulators of intracellular chloride concentration |
|---|---|
| Thematic area | Health |
| Ownership | FONDAZIONE TELETHON, ISTITUTO ITALIANO DI TECNOLOGIA - sede di Genova, UNIVERSITA' DEGLI STUDI DI GENOVA, ALMA MATER STUDIORUM - UNIVERSITA' DI BOLOGNA |
| Inventors | ANNALISA SAVARDI, LAURA CANCEDDA, ANDREA CONTESTABILE, MARCO DE VIVO, Marco Borgogno |
| Protection | International (PCT) |
| Licensing status | not availablefor license agreement |
| Filed on | 02 April 2019 |
Page published on: 06 May 2019